MC16促进线粒体生物发生,改善急性和糖尿病病
Austin D Thompson1,2,3, Kevin A Hurtado1,3, Jaroslav Janda1
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
British journal of pharmacology
|January 31, 2025
概括
一种新型化合物,MC16,有效诱导线粒体生物发生 (MB) 以防止病 (KD). 这种药物在急性损伤和糖尿病病模型中显示出治疗潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 病 (KD) 影响全球人口的10%以上,糖尿病和急性损伤 (AKI) 是主要原因.
- 糖尿病和AKI都会诱导线粒体功能障碍,导致脏近端管道损伤.
- 线粒体生物发生 (MB) 的药理学诱导为KD提供了潜在的治疗策略.
研究的目的:
- 评估新型诱导MB的oxindole剂MC16,其药理和治疗效果.
- 评估MC16能够减轻由代谢和急性攻击引起的损伤的能力.
主要方法:
- 评估了MC16的细胞信号传递和MB诱导作用在子脏近端管细胞 (RPTC) 中.
- 在小鼠体内研究确定了MC16的MB诱导能力及其对皮质代谢组的影响.
- 在AKI和糖尿病病 (DKD) 的小鼠模型中评估了治疗潜力.
主要成果:
- MC16激活PI3K-AKT-eNOS-FOXO1通路,在RPTC和小鼠中诱导MB.
- MC16治疗改善了脏恢复,降低了血管透性,并减少了AKI后线粒体功能障碍.
- 在DKD模型中,MC16减少了脏胀,改善了脏和线粒体功能,减少了间歇性纤维化.
结论:
- MC16是一种新型化合物,可在小鼠模型中诱导MB并改善急性和糖尿病病.
- 向MB后或代谢侮辱提供了一个有希望的治疗策略来管理KD.
- MC16在治疗脏疾病方面具有显著的潜力.
更多相关视频
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
113
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
7.9K
相关概念视频
01:37Mitochondria
9.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.9K
01:46Electron Transport Chain: Complex I and II
10.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.6K